{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:43:06Z","timestamp":1793241786849,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jtha.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:07:47Z","timestamp":1718842067000},"page":"2404-2409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementation"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-792X","authenticated-orcid":false,"given":"Fionnuala","family":"N\u00ed \u00c1inle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"DiMichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich V.","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ampaiwan","family":"Chuansumrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.06.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hae.13862","article-title":"Achieving the unimaginable: health equity in haemophilia","volume":"26","author":"Skinner","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib2","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.jtha.2024.05.026","article-title":"International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Hemophilia A and B based on the GRADE methodology","volume":"22","author":"Rezende","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.002_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.06.002_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jth.12320","article-title":"A\u00a0guide to GRADE guidelines for the readers of JTH","volume":"11","author":"Guyatt","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.002_bib5","series-title":"Clinical practice guidelines we can trust","year":"2011"},{"key":"10.1016\/j.jtha.2024.06.002_bib6","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.06.002_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.002_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.002_bib9","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.002_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12874-019-0713-0","article-title":"Strategies for eliciting and synthesizing evidence for guidelines in rare diseases","volume":"19","author":"Pai","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jtha.2024.06.002_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17474086.2024.2353761","article-title":"How clinicians and persons with hemophilia may approach shared decision-making","volume":"17","author":"Thornburg","year":"2024","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2024.06.002_bib12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jtha.2024.06.003","article-title":"Evidence, what\u2019s in a name? Some methodological remarks on the GRADE approach for guideline development","volume":"22","author":"Dekkers","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib14","first-page":"632","article-title":"Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia","volume":"24","author":"Thorat","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jtha.2024.06.002_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/hae.14998","article-title":"Haemophilia care in Asia: learning from clinical practice in some Asian countries","volume":"30","author":"Angchaisuksiri","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vhri.2014.02.008","article-title":"Cost-utility analysis of home-based care for treatment of Thai hemophilia A and B","volume":"3","author":"Pattanaprateep","year":"2014","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jtha.2024.06.002_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-023-02718-1","article-title":"Practices and challenges for hemophilia management under resource constraints in Thailand","volume":"18","author":"Moonla","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2024.06.002_bib18","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1111\/j.1365-2516.2012.02871.x","article-title":"Incremental cost effectiveness analysis for Haemophilia Home-Based Care Programme in Thailand","volume":"18","author":"Sooksriwong","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vhri.2020.04.007","article-title":"Importance of evidence-based health insurance reimbursement and health technology assessment for achieving universal health coverage and improved access to health in India","volume":"24","author":"Dang","year":"2021","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jtha.2024.06.002_bib20","series-title":"Guide to national tenders for the purchase of clotting factor concentrates","author":"O\u2019Mahony","year":"2015"},{"key":"10.1016\/j.jtha.2024.06.002_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjebm-2023-112492","article-title":"Cost-effectiveness of emicizumab prophylaxis for haemophilia A with inhibitors: an adaptive health technology assessment for the Indian setting","author":"Kar","year":"2024","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jtha.2024.06.002_bib22","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/hae.14143","article-title":"Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea","volume":"27","author":"Lee","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2516.2005.01085.x","article-title":"Knocking down the price of factor concentrates in Brazil","volume":"11","author":"Rezende","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2516.2008.01907.x","article-title":"Registry of inherited coagulopathies in Brazil: first report","volume":"15","author":"Rezende","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.002_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13023-016-0560-6","article-title":"Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias","volume":"12","author":"Rezende","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2024.06.002_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/bloodadvances.2019GS121559","article-title":"Building the National Program of Inherited Bleeding Disorders in Brazil","volume":"3","author":"Rezende","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.002_bib30","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002720","article-title":"Insurance companies\u2019 poor adherence to guidelines for moderate-to-severe ulcerative colitis\/Crohn\u2019s disease management","author":"Anderson","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.06.002_bib33","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jtha.2024.05.035","article-title":"Pros and cons of the ISTH treatment guidelines for hemophilia","volume":"22","author":"Mannucci","year":"2024","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:02:16Z","timestamp":1756699336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1538783624003532"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}